首页> 外文期刊>American Journal of Pathology: Official Publication of the American Association of Pathologists >A mouse model of chikungunya virus-induced musculoskeletal inflammatory disease: evidence of arthritis, tenosynovitis, myositis, and persistence.
【24h】

A mouse model of chikungunya virus-induced musculoskeletal inflammatory disease: evidence of arthritis, tenosynovitis, myositis, and persistence.

机译:基孔肯雅病毒诱发的肌肉骨骼炎性疾病的小鼠模型:关节炎,腱鞘炎,肌炎和持续性的证据。

获取原文
获取原文并翻译 | 示例
       

摘要

Chikungunya virus (CHIKV), an emerging mosquito-borne Alphavirus, causes debilitating rheumatic disease in humans that can last for weeks to months. Starting in 2004, a CHIKV outbreak in the Indian Ocean region affected millions of people, and infected travelers introduced CHIKV to new regions. The pathogenesis of CHIKV is poorly understood, and no approved vaccines or specific therapies exist. A major challenge to the study of CHIKV disease is the lack of a small animal model that recapitulates the major outcomes of human infection. In this study, the pathogenesis of CHIKV in C57BL/6J mice was investigated using biological and molecular clones of CHIKV isolated from human serum (CHIKV SL15649). After 14-day-old mice were inoculated with CHIKV SL15649 in the footpad, they displayed reduced weight gain and swelling of the inoculated limb. Histologic analysis of hind limb sections revealed severe necrotizing myositis, mixed inflammatory cell arthritis, chronic active tenosynovitis, and multifocal vasculitis. Interestingly, these disease signs and viral RNA persisted in musculoskeletal tissues for at least 3 weeks after inoculation. This work demonstrates the development of a mouse model of CHIKV infection with clinical manifestations and histopathologic findings that are consistent with the disease signs of CHIKV-infected humans, providing a useful tool for studying viral and host factors that drive CHIKV pathogenesis and for evaluating potential therapeutics against this emerging viral disease.
机译:基孔肯雅病毒(CHIKV)是一种新兴的蚊媒Alpha病毒,可导致人类衰弱的风湿病,持续数周至数月。从2004年开始,印度洋地区的一次CHIKV爆发影响了数百万人,受感染的旅行者将CHIKV引入了新的地区。 CHIKV的发病机理知之甚少,并且不存在批准的疫苗或特定疗法。 CHIKV疾病研究的一个主要挑战是缺少一个小动物模型来概括人类感染的主要结果。在这项研究中,CHIKV在C57BL / 6J小鼠中的发病机理是使用从人血清中分离出的CHIKV的生物学和分子克隆(CHIKV SL15649)进行研究的。在14天大的小鼠的脚垫中接种CHIKV SL15649后,它们的体重增加减少,并且被接种肢体肿胀。后肢切片的组织学分析显示严重坏死性肌炎,混合性炎性细胞关节炎,慢性活动性腱鞘炎和多灶性血管炎。有趣的是,这些疾病迹象和病毒RNA在接种后至少在肌肉骨骼组织中持续3周。这项工作展示了CHIKV感染小鼠模型的发展,其临床表现和组织病理学发现与CHIKV感染人类的​​疾病征象相一致,为研究驱动CHIKV发病机理的病毒和宿主因素以及评估潜在的治疗方法提供了有用的工具。针对这种新兴的病毒性疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号